The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biomarker analysis of glioblastoma and potential implications for therapy.
Joanne Xiu
Employment or Leadership Position - Caris Life Sciences
Rebecca Anne Feldman-Moreno
Employment or Leadership Position - Caris Life Sciences
Expert Testimony - Caris Life Sciences (U)
David Arguello
Employment or Leadership Position - Caris Life Sciences
Zoran Gatalica
Stock Ownership - Caris Life Sciences
Anatole Ghazalpour
Employment or Leadership Position - Caris Life Sciences
Ryan P. Bender
Employment or Leadership Position - Caris Life Sciences (I)
Stock Ownership - Caris Life Sciences
Expert Testimony - Caris Life Sciences (U)
Michael Castro
Consultant or Advisory Role - Caris Life Sciences
Honoraria - Caris Life Sciences
Sandeep K. Reddy
Employment or Leadership Position - Caris Life Sciences
Consultant or Advisory Role - Caris Life Sciences
Gargi Dan Basu
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Les Paul
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences